Contact Dermatitis is designed primarily as a journal for clinicians who are interested in various aspects of environmental dermatitis. This includes both allergic and irritant (toxic) types of contact dermatitis, occupational (industrial) dermatitis and consumers' dermatitis from such products as cosmetics and toiletries. Delayed hypersensitivity reactions to systemic drugs and implanted medical devices where cutaneous testing has been utilised are also of interest.

The journal aims at promoting and maintaining communication among dermatologists, occupational physicians, allergists and clinical immunologists, as well as chemists and research workers.

Papers are invited on clinical observations, diagnosis and methods of investigation of patients, therapeutic measures, organisation and legislation relating to the control of occupational and consumers' contact dermatitis, preventive measures and educational advice.

A major section is devoted to Short Communications for the presentation of information on new contact allergens or other substances.

Papers concerned with the chemistry and immunology of allergic contact dermatitis are invited for the purpose of bringing to the notice of the clinician, knowledge of important recent advances in the understanding of its theoretical basis, as well as papers on the physiology and pathology of the horny layer and epidermis in relation to its disturbance in the genesis of irritant dermatitis.

Editor-in-Chief
Wolfgang Uter
University of Erlangen
Dept. of Med. Informatics, Biometry & Epidemiology
Waldstr. 6, D-91054 Erlangen
Germany
E-mail: wolfgang.uter@imbe.med.uni-erlangen.de

Co-Editors
Jeanne Duus Johansen
Ian R. White

Editor Emeritus
Torkil Menné

Section Editors

Clinical Studies: Margarida Gonçalo, mmgoncalo@gmail.com

Epidemiology: Jacob P. Thyssen, jacob.pontoppidan.thyssen@regionh.dk

Immunology: Stefan F. Martin, stefan.martin@uniklinik-freiburg.de

Molecular Aspects and Skin Metabolism: Jean-Pierre Lepoittevin, jplepoit@unistra.fr

Occupational Dermatology: Kristiina Aalto-Korte, kristiina.aalto-Korte@ttl.fi

Risk Assessment: Carola Lidén, carola.liden@ki.se

Editorial Advisory Board

Olivier Aerts, Belgium, olivier.aerts@uza.be

Klaus Andersen, Denmark, klaus.ejner.andersen@rsyd.dk

Annick Barbaud, France, a.barbaud@chu-nancy.fr

Anna Börje, Sweden, aborje@chem.gu.se

Magnus Bruze (Chairman ESCD), Sweden, magnus.bruze@med.lu.se

Marie-Noëlle Crépy, France, marie-noelle.crepy@orange.fr

Peter Elsner, Germany, elsner@derma-jena.de

Johannes Geier, Germany, jgeier@gwdg.de

Nicola Gilmour, UK, nicola.gilmour@unilever.com

Ana Giménez-Arnau, Spain, 22505aga@comb.cat

Elena Giménez-Arnau, France, egimenez@chimie.u-strasbg.fr

An Goossens, Belgium, an.goossens@uzleuven.be

Marléne Isaksson, Sweden, marlene.isaksson@med.lu.se (skane.se)

Swen Malte John, Germany, sjohn@uni-osnabrueck.de

Anneli Julander, Sweden, anneli.julander@ki.se

Vera Mahler, Germany, vera.mahler@uk-erlangen.de

Rosemary Nixon, Australia, rnixon@occderm.asn.au

Evy Paulsen, Denmark, evy.paulsen@rsyd.dk

Thomas Rustemeyer, The Netherlands, t.rustemeyer@vumc.nl

Marie-Louise Schuttelaar, The Netherlands, m.l.a.schuttelaar@umcg.nl

Katri Suuronen, Finland, katri.suuronen@ttl.fi

Erin Warshaw, USA, erin.warshaw@va.org

Mark Wilkinson, UK, mark.wilkinson15@nhs.net

Kathryn Zug, USA, kathryn.a.zug@hitchcock.org